![Todd Wider](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Wider
Direttore/Membro del Consiglio presso
ASP ISOTOPES INC.
Patrimonio netto: 3 M $ in data 31/07/2026
Profilo
Todd Wider is currently Director at Varian Biopharmaceuticals, Inc., Director at Varian Biopharma, Inc., Independent Non-Executive Director at ASP Isotopes, Inc. since 2021, Independent Director at Genenta Science SpA since 2024, and Principal at Wider Film Projects.
Former roles include Executive Chairman & Chief Medical Officer at Emendo Biotherapeutics, Inc. from 2018 to 2024, Independent Director at Abeona Therapeutics, Inc., Independent Director at ARYA Sciences Acquisition Corp.
from 2018 to 2020, Independent Director at ARYA Sciences Acquisition Corp.
II in 2020, Independent Director at ARYA Sciences Acquisition Corp.
IV, Independent Director at ARYA Sciences Acquisition Corp.
V, Independent Director at ARYA Sciences Acquisition Corp.
III from 2020 to 2021, Director at Lyfebulb LLC, and Principal at Memorial Sloan Kettering Cancer Center.
Education includes undergraduate studies at Princeton University and a doctorate from Columbia University College of Physicians & Surgeons.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ASP ISOTOPES, INC. 0,53% | 30/06/2026 | 672.247 ( 0,53% ) | 3 M $ | 31/07/2026 |
Posizioni attive di Todd Wider
| Società | Posizione | Inizio |
|---|---|---|
| ASP ISOTOPES INC. | Direttore/Membro del Consiglio | 01/10/2021 |
| GENENTA SCIENCE S.P.A. | Direttore/Membro del Consiglio | 02/05/2024 |
Wider Film Projects | Corporate Officer/Principal | - |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Todd Wider
| Società | Posizione | Fine |
|---|---|---|
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Presidente | 01/03/2024 |
| ARYA SCIENCES ACQUISITION III A | Direttore/Membro del Consiglio | 01/06/2021 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/11/2020 |
| ARYA SCIENCES ACQUISITION CORP. | Direttore/Membro del Consiglio | 01/03/2020 |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
Formazione di Todd Wider
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
45
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Lyfebulb LLC
 Lyfebulb LLC Internet Software/ServicesTechnology Services Operates as an online digital platform for people living with chronic illnesses | Technology Services |
Wider Film Projects | |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
ASP Isotopes, Inc.
 ASP Isotopes, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes | Health Technology |
